EPHA2 mutations contribute to congenital cataract through diverse mechanisms

Molecular Vision

Volumn 22, Issue , 2016, Pages 18-30

  Dave, Alpana ^a   Martin, Sarah ^a   Kumar, Raman ^b,c   Craig, Jamie E ^a   Burdon, Kathryn P ^a   Sharma, Shiwani ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN RECEPTOR A2; MYC PROTEIN; PRIMER DNA;

ANIMAL CELL; ARTICLE; CONGENITAL CATARACT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; EPHA2 GENE; EPITHELIUM CELL; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MUTAGENESIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; ANIMAL; CACO-2 CELL LINE; CATARACT; CELL LINE; DOG; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; INDIRECT FLUORESCENT ANTIBODY TECHNIQUE; MDCK CELL LINE; METABOLISM; MUTATION; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CACO-2 CELLS; CATARACT; CELL LINE; DNA PRIMERS; DOGS; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MADIN DARBY CANINE KIDNEY CELLS; MUTATION; RECEPTOR, EPHA2; TRANSFECTION;

EID: 84957110986     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Shiels A, Bennett TM, Hejtmancik JF. Cat-Map: putting cataract on the map. Mol Vis 2010; 16:2007-15. [PMID: 21042563].
2. Apple DJ, Ram J, Foster A, Peng Q. Elimination of cataract blindness: a global perspective entering the new mille­nium. Surv Ophthalmol 2000; 45:Suppl 191-196. [PMID: 11291895].
3. Gilbert C, Foster A. Childhood blindness in the context of VISION 2020–the right to sight. Bull World Health Organ 2001; 79:227-32. [PMID: 11285667].
4. Rahi JS, Sripathi S, Gilbert CE, Foster A. Childhood blindness in India: causes in 1318 blind school students in nine states. Eye (Lond) 1995; 9:545-50. [PMID: 8543070].
5. Shiels A, Bennett TM, Knopf HL, Maraini G, Li A, Jiao X, Hejtmancik JF. The EPHA2 gene is associated with cata­racts linked to chromosome 1p. Mol Vis 2008; 14:2042-55. [PMID: 19005574].
6. Zhang T, Hua R, Xiao W, Burdon KP, Bhattacharya SS, Craig JE, Shang D, Zhao X, Mackey DA, Moore AT, Luo Y, Zhang J, Zhang X. Mutations of the EPHA2 receptor tyrosine kinase gene cause autosomal dominant congenital cataract. Hum Mutat 2009; 30:E603-11. [PMID: 19306328].
7. Kaul H, Riazuddin SA, Shahid M, Kousar S, Butt NH, Zafar AU, Khan SN, Husnain T, Akram J, Hejtmancik JF, Riazuddin S. Autosomal recessive congenital cataract linked to EPHA2 in a consanguineous Pakistani family. Mol Vis 2010; 16:511-7. [PMID: 20361013].
8. Shentu XC, Zhao SJ, Zhang L, Miao Q. A novel p.R890C muta­tion in EPHA2 gene associated with progressive childhood posterior cataract in a Chinese family. Int J Ophthalmol 2013; 6:34-8. [PMID: 23447127].
9. Aldahmesh MA, Khan AO, Mohamed JY, Hijazi H, Al-Owain M, Alswaid A, Alkuraya FS. Genomic analysis of pediatric cataract in Saudi Arabia reveals novel candidate disease genes. Genet Med 2012; 14:955-62. [PMID: 22935719].
10. Dave A, Laurie K, Staffieri SE, Taranath D, Mackey DA, Mitchell P, Wang JJ, Craig JE, Burdon KP, Sharma S. Muta­tions in the EPHA2 gene are a major contributor to inherited cataracts in South-Eastern Australia. PLoS One 2013; 8:e72518-[PMID: 24014202].
11. Jun G, Guo H, Klein BE, Klein R, Wang JJ, Mitchell P, Miao H, Lee KE, Joshi T, Buck M, Chugha P, Bardenstein D, Klein AP, Bailey-Wilson JE, Gong X, Spector TD, Andrew T, Hammond CJ, Elston RC, Iyengar SK, Wang B. EPHA2 is associated with age-related cortical cataract in mice and humans. PLoS Genet 2009; 5:e1000584-[PMID: 19649315].
12. Pasquale EB. Eph receptors and ephrins in cancer: bidirec­tional signalling and beyond. Nat Rev Cancer 2010; 10:165-80. [PMID: 20179713].
13. Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008; 133:38-52. [PMID: 18394988].
14. McAvoy JW, Chamberlain CG, de Iongh RU, Hales AM, Lovicu FJ. Lens development. Eye (Lond) 1999; 13:Pt 3b425-37. [PMID: 10627820].
15. Rosenberg IM, Goke M, Kanai M, Reinecker HC, Podolsky DK. Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function. Am J Physiol 1997; 273:G824-32. [PMID: 9357823].
16. Tessier-Lavigne M. Eph receptor tyrosine kinases, axon repul­sion, and the development of topographic maps. Cell 1995; 82:345-8. [PMID: 7634322].
17. Mori T, Wanaka A, Taguchi A, Matsumoto K, Tohyama M. Differential expressions of the eph family of receptor tyro­sine kinase genes (sek, elk, eck) in the developing nervous system of the mouse. Brain Res Mol Brain Res 1995; 29:325-35. [PMID: 7609620].
18. Sefton M, Araujo M, Nieto MA. Novel expression gradients of Eph-like receptor tyrosine kinases in the developing chick retina. Dev Biol 1997; 188:363-8. [PMID: 9268581].
19. Shi Y, De Maria A, Bennett T, Shiels A, Bassnett S. A Role for Epha2 in Cell Migration and Refractive Organization of the Ocular Lens. Invest Ophthalmol Vis Sci 2012; 53:551-9. [PMID: 22167091].
20. Son AI, Cooper MA, Sheleg M, Sun Y, Kleiman NJ, Zhou R. Further analysis of the lens of ephrin-A5−/− mice: develop­ment of postnatal defects. Mol Vis 2013; 19:254-66. [PMID: 23401654].
21. Lindberg RA, Hunter T. cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases. Mol Cell Biol 1990; 10:6316-24. [PMID: 2174105].
22. Miyoshi J, Takai Y. Molecular perspective on tight-junction assembly and epithelial polarity. Adv Drug Deliv Rev 2005; 57:815-55. [PMID: 15820555].
23. Tanaka M, Kamata R, Sakai R. EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability. J Biol Chem 2005; 280:42375-82. [PMID: 16236711].
24. Zantek ND, Azimi M, Fedor-Chaiken M, Wang B, Bracken­bury R, Kinch MS. E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ 1999; 10:629-38. [PMID: 10511313].
25. Orsulic S, Kemler R. Expression of Eph receptors and ephrins is differentially regulated by E-cadherin. J Cell Sci 2000; 113:1793-802. [PMID: 10769210].
26. Fang WB, Ireton RC, Zhuang G, Takahashi T, Reynolds A, Chen J. Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism. J Cell Sci 2008; 121:358-68. [PMID: 18198190].
27. Wakayama Y, Miura K, Sabe H, Mochizuki N. EphrinA1-EphA2 signal induces compaction and polarization of Madin-Darby canine kidney cells by inactivating ezrin through negative regulation of RhoA. J Biol Chem 2011; 286:44243-53. [PMID: 21979959].
28. Bassnett S, Shi Y, Vrensen GF. Biological glass: structural determinants of eye lens transparency. Philos Trans R Soc Lond B Biol Sci 2011; 366:1250-64. [PMID: 21402584].
29. Cheng C, Ansari MM, Cooper JA, Gong X. EphA2 and Src regulate equatorial cell morphogenesis during lens develop­ment. Development 2013; 140:4237-45. [PMID: 24026120].
30. Dave A, Craig JE, Sharma S. The status of intercellular junc­tions in established lens epithelial cell lines. Mol Vis 2012; 18:2937-46. [PMID: 23288986].
31. Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989; 96:736-49. [PMID: 2914637].
32. Sharma S, Burdon KP, Dave A, Jamieson RV, Yaron Y, Billson F, Van Maldergem L, Lorenz B, Gecz J, Craig JE. Novel caus­ative mutations in patients with Nance-Horan syndrome and altered localization of the mutant NHS-A protein isoform. Mol Vis 2008; 14:1856-64. [PMID: 18949062].
33. Sharma S, Koh KS, Collin C, Dave A, McMellon A, Sugiyama Y, McAvoy JW, Voss AK, Gecz J, Craig JE. NHS-A isoform of the NHS gene is a novel interactor of ZO-1. Exp Cell Res 2009; 315:2358-72. [PMID: 19447104].
34. Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 2005; 6:462-75. [PMID: 15928710].
35. Lewin B. Protein Trafficking. In: Carlson G, editor. Genes VIII: Pearson Prentice Hall; 2004. p. 787–791.
36. Park JE, Son AI, Hua R, Wang L, Zhang X, Zhou R. Human Cataract Mutations in EPHA2 SAM Domain Alter Receptor Stability and Function. PLoS One 2012; 7:e36564-[PMID: 22570727].
37. Smalla M, Schmieder P, Kelly M, Ter Laak A, Krause G, Ball L, Wahl M, Bork P, Oschkinat H. Solution structure of the receptor tyrosine kinase EphB2 SAM domain and identifica­tion of two distinct homotypic interaction sites. Protein Sci 1999; 8:1954-61. [PMID: 10548040].
38. Harris BZ, Lim WA. Mechanism and role of PDZ domains in signaling complex assembly. J Cell Sci 2001; 114:3219-31. [PMID: 11591811].
39. Hock B, Bohme B, Karn T, Yamamoto T, Kaibuchi K, Holtrich U, Holland S, Pawson T, Rubsamen-Waigmann H, Strebhardt K. PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor. Proc Natl Acad Sci USA 1998; 95:9779-84. [PMID: 9707552].
40. Furuse M, Izumi Y, Oda Y, Higashi T, Iwamoto N. Molecular organization of tricellular tight junctions. Tissue Barriers